Hector Alejandro Ruiz-Moreno (Héctor Alejandro Ruiz-Moreno)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Gene Expression

Advanced Non Small Cell Lung Cancer

Respiratory Syndrome Coronavirus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Diego Alejandro Álvarez-Díaz, Ana Luisa Muñoz, María T Herrera-Sepúlveda, Pilar Tavera-Rodríguez, Katherine Laiton-Donato, Carlos Franco-Muñoz, Hector Alejandro Ruiz-Moreno, Marisol Galindo, Jenssy D Catama, Andrea Bermudez-Forero, Marcela Mercado-Reyes
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia. Vaccines 10 (12) (2022)
Diego Alejandro Álvarez-Díaz, Ana Luisa Muñoz, María T Herrera-Sepúlveda, Pilar Tavera-Rodríguez, Katherine Laiton-Donato, Carlos Franco-Muñoz, Hector Alejandro Ruiz-Moreno, Marisol Galindo, Jenssy D Catama, Andrea Bermudez-Forero, Marcela Mercado-Reyes
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia. Vaccines 10 (12) (2022)
Diego Alejandro Álvarez-Díaz, Ana Luisa Muñoz, María T Herrera-Sepúlveda, Pilar Tavera-Rodríguez, Katherine Laiton-Donato, Carlos Franco-Muñoz, Hector Alejandro Ruiz-Moreno, Marisol Galindo, Jenssy D Catama, Andrea Bermudez-Forero, Marcela Mercado-Reyes
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia. Vaccines 10 (12) (2022)
Diego Alejandro Álvarez-Díaz, Ana Luisa Muñoz, María T Herrera-Sepúlveda, Pilar Tavera-Rodríguez, Katherine Laiton-Donato, Carlos Franco-Muñoz, Hector Alejandro Ruiz-Moreno, Marisol Galindo, Jenssy D Catama, Andrea Bermudez-Forero, Marcela Mercado-Reyes
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia. Vaccines 10 (12) (2022)
Diego Alejandro Álvarez-Díaz, Ana Luisa Muñoz, Pilar Tavera-Rodríguez, María T Herrera-Sepúlveda, Hector Alejandro Ruiz-Moreno, Katherine Laiton-Donato, Carlos Franco-Muñoz, Dioselina Pelaez-Carvajal, Diego Cuellar, Alejandra M Muñoz-Suarez, Marisol Galindo, Edgar J Arias-Ramírez, Marcela Mercado-Reyes
Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia. Vaccines 10 (2) (2022)